Evogene's minority interest is $11M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Evogene posts a minority interest of $11M as of March 2026. That compares with $16M in the prior-year period — down 34.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Evogene's minority interest was $16M. The latest reading is $11M — a 34.3% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.
Minority Interest is one piece of Evogene's financial statement story. At $11M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for EVGN's minority interest usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Evogene's other metric pages and overview cover the third.
Judging Evogene against Materials peers is usually better than using a market-wide rule of thumb. Business models inside Materials are more comparable, which makes gaps in minority interest easier to interpret. Start with $11M here, then scan peer and history charts to see if the gap is persistent.